Search hospitals > California > Riverside
Clinical Innovations Inc.
Claim this profileRiverside, California 92506
Global Leader in Schizophrenia
Conducts research for Depression
Conducts research for Major Depressive Disorder
Conducts research for Sleep Disorders
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
23 reported clinical trials
2 medical researchers
Summary
Clinical Innovations Inc. is a medical facility located in Riverside, California. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Sleep Disorders, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Clinical Innovations Inc. is involved with conducting 23 clinical trials across 18 conditions. There are 2 research doctors associated with this hospital, such as Robert Bota, MD and Gerald A Maguire, MD.Top PIs
Robert Bota, MDBrainHealth Solutions1 year of reported clinical research
Studies Schizophrenia
Studies Alzheimer's Disease
5 reported clinical trials
8 drugs studied
Gerald A Maguire, MDClinical Innovations, Inc2 years of reported clinical research
Studies Schizophrenia
Studies Bipolar Depression
2 reported clinical trials
4 drugs studied
Clinical Trials running at Clinical Innovations Inc.
Schizophrenia
Depression
Bipolar Depression
Long-term Safety of Iclepertin
for Schizophrenia
This study is open to adults with schizophrenia who took part in a previous CONNEX study (study 1346-0011, 1346-0012, or 1346-0013). The purpose of this study is to find out how well people with schizophrenia can tolerate a medicine called Iclepertin in the long term. Participants take Iclepertin as tablets once a day for 1 year. In addition, all participants take their normal medication for schizophrenia. Participants are in the study for a little more than 1 year. During this time, they visit the study site about 13 times and get about 9 phone calls from the study team. The doctors collect information on any health problems of the participants. Doctors also regularly check the participants' symptoms of schizophrenia.
Recruiting2 awards Phase 35 criteria
KarXT
for Schizophrenia
This trial tests the safety and tolerability of KarXT, a combination of two drugs, in schizophrenia patients who haven't responded well to their current treatments. KarXT aims to improve symptoms and manage side effects better than existing medications. KarXT (xanomeline plus trospium) is an emerging treatment for schizophrenia, showing promise in managing total, positive, and negative symptoms.
Recruiting2 awards Phase 35 criteria
KarXT
for Schizophrenia
This trial tests KarXT, a combination of two drugs, for people who haven't improved with their current treatment. KarXT aims to balance brain functions and reduce side effects. The study will look at improvements in health and daily life. KarXT has shown positive results in earlier tests.
Recruiting1 award Phase 321 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Clinical Innovations Inc.?
Clinical Innovations Inc. is a medical facility located in Riverside, California. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Sleep Disorders, Attention Deficit Hyperactivity Disorder (ADHD) and other specialties. Clinical Innovations Inc. is involved with conducting 23 clinical trials across 18 conditions. There are 2 research doctors associated with this hospital, such as Robert Bota, MD and Gerald A Maguire, MD.